Cassava Sciences, Inc.
(NASDAQ : SAVA)

( )
SAVA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. -1.85%26.0114.1%$153.05m
AMRNAmarin Corp. Plc -1.95%17.581.7%$96.60m
CTLTCatalent, Inc. -5.15%55.942.2%$75.57m
JAZZJazz Pharmaceuticals Plc -2.94%130.862.3%$58.94m
UTHRUnited Therapeutics Corp. 7.84%115.3514.3%$57.82m
RVMDRevolution Medicines, Inc. 0.92%30.700.0%$55.28m
GWPHGW Pharmaceuticals Plc -3.95%120.726.2%$53.63m
AXSMAxsome Therapeutics, Inc. -2.88%88.511.9%$52.07m
ZGNXZogenix, Inc. -4.21%28.899.4%$42.94m
PRGOPerrigo Co. Plc -1.04%59.246.8%$41.91m
HZNPHorizon Therapeutics Plc -2.82%34.506.6%$38.73m
SAGESAGE Therapeutics, Inc. -3.44%67.148.6%$37.60m
ICPTIntercept Pharmaceuticals, Inc. -4.32%90.8916.9%$36.34m
ENDPEndo International Plc -1.15%6.008.8%$34.32m
ICLRICON plc -4.33%163.574.2%$31.13m

Company Profile

Cassava Sciences, Inc. engages in the development of novel drugs. It focuses on developing product candidates intended for the treatment of Alzheimer's disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.